Healthcare Cost Associated with an Acute Mental Healthcare Bundle in Pediatric Emergency Departments [0.03%]
儿科急诊部门急性精神卫生保健包的相关医疗费用
Lola Ibraimova,Amanda S Newton,Stephen B Freedman et al.
Lola Ibraimova et al.
Objective: To evaluate healthcare cost associated with a standardized mental healthcare bundle in two tertiary pediatric emergency departments (EDs) in Alberta, Canada. ...
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain [0.03%]
西班牙慢性炎症性脱髓鞘多发神经病患者免疫球蛋白维持治疗的成本分析
Sofía de Pedro,María Presa,Josep Gamez et al.
Sofía de Pedro et al.
Background/objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, immune-mediated disorder, which causes peripheral nervous system dysfunction. Guidelines recommend maintenance treatment with intra...
Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs [0.03%]
抗生素可转让性排他延期券：激励设计、实施挑战及政策权衡
Mario García-Díaz,Jorge Mestre-Ferrándiz,Jaime Espín
Mario García-Díaz
Antimicrobial resistance (AMR) is one of the greatest threats to public health, and forecasts for 2050 are even worse. In response, the European Commission (EC) is proposing the Transferable Exclusivity Extension Voucher (TEEV), which aims ...
Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial [0.03%]
重复进行胎盘生长因子检测与常规护理在疑似子痫前期妇女中的成本比较：PARROT-2试验
Alice Hurrell,Louise Webster,Jenie Sparkes et al.
Alice Hurrell et al.
Objectives: The aim was to evaluate health resource use and cost, and conduct a cost comparison of repeat placental growth factor (PlGF)-based testing for suspected pre-eclampsia, compared with usual care. ...
Eric Julian Manalastas,Aditi Hombali,Juliette C Thompson et al.
Eric Julian Manalastas et al.
Objectives: Retractions of scientific articles have increased over time, across different health fields, disease indications, and study designs. However, it is currently unknown whether, and to what extent, retractions ha...
Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and Management [0.03%]
不同癌症筛查和治疗成本趋势下的多重癌症早期检测的潜在经济价值
Anuraag R Kansal,Ali Tafazzoli,Weicheng Ye et al.
Anuraag R Kansal et al.
Objectives: Multi-cancer early detection (MCED) tests aim to reduce the clinical and economic burden of cancer by detecting cases at earlier, more treatable stages. Recent trends indicate that the costs of cancer manageme...
Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer Screening [0.03%]
LungFlag肺部癌症筛查预测模型的影响因素预算分析
Carolina Heuser,Michael K Gould,Eran Choman et al.
Carolina Heuser et al.
Background/objective: Lung cancer screening has historically been associated with false-positive results that can lead to complications and increased costs. LungFlag is a machine-learning risk prediction model using indiv...
Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling [0.03%]
基于真实世界数据和患者模拟建模的英格兰全民医疗保健系统第二类糖尿病缓解试点方案的经济评估证据
Adam Martin,Tayamika Zabula,Davide Tebaldi et al.
Adam Martin et al.
Background: The 'Type 2 Diabetes Path to Remission' programme (T2DPR) of NHS England (NHSE) is a low-calorie diet intervention with behavioural support for adults with a recent type 2 diabetes mellitus (T2D) diagnosis and...
Use of Health State Utility Values in Cost-Utility Analyses of Selected Infectious Diseases in Aging Populations: A Systematic Review and Critical Appraisal [0.03%]
老龄化人群中传染病成本效益分析中健康状态效用值的运用：系统综述与批判性评价
Thi Hao Pham,Jovan Mihajlović,Ivan Loncar et al.
Thi Hao Pham et al.
Background: Health state utility values (HSUVs) are vital in cost-utility analyses (CUAs) that inform policymaking. However, suboptimal selection and application of HSUVs have been reported in areas such as cardiovascular...
Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review [0.03%]
嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤的 cost-effectiveness：一项更新的系统综述
Nishma Patel,Suzanne Farid,Manuel Gomes
Nishma Patel
Background: Chimeric antigen receptor (CAR) T-cell therapy is an area of rapid development, showing the promise of curing blood cancers. While substantial health gains may justify high costs, it is currently unclear the e...